Cancer vaccines Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
03:46
Jan 15
Jan 15
Cancer vaccines advance with faster sequencing.
Cancer vaccines are entering clinical trials at scale. Faster gene sequencing allows identification of tumor neoantigens, which can be delivered to activate dendritic cells and T cells against tumors. He says this is an area investors should watch, though it likely needs combination with other immuno-oncology drugs.
MED
About Cancer vaccines Investor Commentary
Across the available history and selected sources, Buzzberg tracks Cancer vaccines across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Yoon Ju-han.